×

Salix & Allergan in serious talks

9:14 AM ET Tue, 23 Sept 2014

CNBC's David Faber reports significant talks are taking place between Allergan and Salix Pharmaceuticals, and how the potential deal impacts Valeant. Jim Cramer explains how Wall Street perceives the potential buy.